Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06296940 · ClinicalTrials.gov registry record · NA
Written Exposure in Substance Treatment
A NA study of Posttraumatic Stress Disorder and Substance Use Disorders, sponsored by Potomac Health Foundations.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06296940 is a NA study of Posttraumatic Stress Disorder and Substance Use Disorders that has completed, run by Potomac Health Foundations. The registered enrollment target is 50 participants, below the 112-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06296940, a NA study of Posttraumatic Stress Disorder and Substance Use Disorders, has completed, sponsored by Potomac Health Foundations.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot randomized clinical trial is to test the feasibility and efficacy of written exposure therapy (WET) for posttraumatic stress disorder (PTSD) within the context of residential substance use disorder (SUD) treatment. All participants meet criteria for PTSD and are in a short term residential SUD treatment program (target residential treatment duration = 28 days) regardless of the research. The main questions the study aims to answer are: 1) Is the delivery of WET feasible in short term residential SUD treatment for individuals with severe SUD; 2) Do participants in the TAU+WET condition have greater reductions in PTSD symptoms pre/post treatment compared to participants in TAU alone?
Conditions Studied
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Written Exposure Therapy
Study Locations (1)
Maryland
- Maryland Treatment Centers - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06296940
The ClinicalTrials.gov registry entry for NCT06296940 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 112-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (55% lower). The listed sponsor is Potomac Health Foundations, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT06296940 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06296940 about?
NCT06296940 is a clinical study titled "Written Exposure in Substance Treatment". The purpose of this pilot randomized clinical trial is to test the feasibility and efficacy of written exposure therapy (WET) for posttraumatic stress disorder (PTSD) within the context of residential substance use disorder (SUD) treatment. All participants meet criteria for PTSD and are in a short ...
What is the current status of trial NCT06296940?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-12-01. Estimated completion is 2024-05-31.
What conditions does trial NCT06296940 study?
This clinical trial studies the following conditions: Posttraumatic Stress Disorder, Substance Use Disorders.
What interventions are being tested in trial NCT06296940?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Written Exposure Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06296940?
This trial is sponsored by Potomac Health Foundations, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06296940 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Posttraumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Impact of Cognitive Behavioral Therapy on PTSD-CVD Link
RECRUITING · NA
-
A Mechanistic Trial of the Neurobiology of Extinction Learning and Intraparietal Sulcus Stimulation
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.